AzTrials
AzTrials

Anxiety and DepressionVIVIMNCT07246239

Evaluating the Effectiveness of an Online Cognitive Behavioral Therapy Program for University Students With Depression and/or Anxiety

A study testing VIVIM (Viure la Vida al Màxim/Vivir la Vida al Máximo) and Counseling in people with Anxiety and Depression, run by University Rovira i Virgili at 3 sites in Spain.

Active, not recruiting

Under way, not looking for participants. Everyone needed has enrolled. The study is still running.

Official record
Search all trials

Trial summary

The goal of this clinical trial is to learn if an Internet-based self-help program called VIVIM can help university students with depression and/or anxiety. The main question investigadors want to answer is: Does the VIVIM program help participants to feel less depressed and/or anxious? The investigators will compare… Read more about this study

Who is it for?
Any age
Conditions the study is for
Anxiety and Depression
What is being tested?
VIVIM (Viure la Vida al Màxim/Vivir la Vida al Máximo) and Counseling
Could I receive a placebo?
No, everyone receives an active treatment
How many people
108 participants
Where
3 sitesSpain
Study dates
15 Sep 2025to Aug 2026
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Any age
  • All sexes
  • No healthy volunteers
  • Child, Adult, Older adult

Who may be able to join

  • To be enrolled as an undergraduate or postgraduate at of the participating Spanish universities.
  • To report at least moderate symptoms of depression (PHQ>o= 10) and/or anxiety (GAD-7>o= 10).

Who cannot join

  • To self-report having been diagnosed with bipolar and/or psychotic disorder.
  • To report to be currently receiving psychotherapy/counselling and/or pharmacological treatment for emotional problems.
  • To be unable to read, speak or understand Spanish.
  • To be at risk of suicide.

Trial locations and contacts

3 sites in 1 country.

Spain3 sites
  • Blanquerna - Universitat Ramon Llull

    Barcelona, Barcelona, 08022

  • Universitat de Girona

    Girona, Girona

  • Universitat Rovira i Virgili

    Tarragona, Tarragona, 43007

Other trials in Spain

About this study

Official title: Evaluating the Effectiveness of an Online Cognitive Behavioral Therapy Program for University Students With Depression and/or Anxiety: A Randomized Controlled Trial

The goal of this clinical trial is to learn if an Internet-based self-help program called VIVIM can help university students with depression and/or anxiety. The main question investigadors want to answer is:

  • Does the VIVIM program help participants to feel less depressed and/or anxious? The investigators will compare the VIVIM program with the usual psychological support that university counselling services offer to students.
Read more

Participants will:

  • Be randomly assigned to either use the VIVIM program or receive usual help from university's counselling service.
  • Fill out online questionnaires three times: at the beginning, 10 weeks and 6 months after being assigned either the VIVIM program or usual care.
Being tested
VIVIM (Viure la Vida al Màxim/Vivir la Vida al Máximo), Counseling
Keywords
cognitive-behavioral treatment, internet-based program, depression, anxiety, students, university
Medical subject headings
Anxiety Disorders, Depression

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • VIVIM (Viure la Vida al Màxim/Vivir la Vida al Máximo)Behavioural

    This is the Internet-based CBT program

  • CounselingOther

    This is the type of support that is offered from the university counseling services

Study groups in NCT07246239
Study groupRoleWhat they receive
Internet-based CBT programExperimentalThis 10-week program consists of 10 modules. Throughout the program, participants progress at their own pace. They have the opportunity to attend two individual support sessions (at the beginning and midway through the program) as well as in weekly group support designed to address questions and reinforce learning. These sessions are conducted via videoconference. Participants also receive weekly automated email remainders and can contact the team via email at any time. This program is an adaptation of Overcoming Low mood and Depresion: A Five Areas Approach.
Receives: Behavioral: VIVIM (Viure la Vida al Màxim/Vivir la Vida al Máximo)
Treatment as usualActive comparatorTreatment as usual involves referral to the counseling service offered by the university to its students.
Receives: Other: Counseling

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Anxiety

    The Generalized Anxiety Disorder [GAD-7] will be used. The total score ranges from 0-21, with a higher score indicating higher symptoms severity

    Measured: From enrollment to 6 months after being randomized

  2. Depression

    The Patient Health Questionnaire-9 item [PHQ-9] will be used. The total score ranges from 0 to 27, with a higher score indicating a higher symptom severity

    Measured: From enrollment to 6 months after being randomized

Secondary outcomes (3)
  1. Functional impairment

    Work and Social Adjustment Scale [WSAS] will be used. The total score ranges from 0 to 40, with higher scores reflecting worse functioning.

    Measured: From enrollment to 6 months after being randomized

  2. Mental well-being

    The Five Well-Being Index (WHO-5) will be used. The total score is the sum of all items, with high scores indicating a better well-being. and the row scores are transformed to a 0 (worst imaginable well-being) -100 (best imaginable well-being) scale

    Measured: From enrollment to 6 months after being randomized

  3. Resilience

    The Connor-Davidson Resilience Scale [CD-RISC-10] will be used. The total score ranges from 0 to 40. Higher scores indicate greater resilience.

    Measured: From enrollment to 6 months after being randomized

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted24 Nov 2025
  2. Study start15 Sep 2025
  3. Primary completionAug 2026 (estimated)
  4. Study completionAug 2026 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Investigator, Outcomes assessor
Enrolment
108 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07246239
Sponsor's protocol ID
CEIPSA-2024-PR-0023 Full RCT
Other IDs
2023 Benes 00023
Acronym
VIVIM
Status last verified
Apr 2026
First submitted
17 Nov 2025
Last updated
5 May 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: Individual participant data that underlie results in a publication will be shared in the data repository of the Univesitat Rovira i Virgili.

Questions about this trial

What is this clinical trial studying?

A study testing VIVIM (Viure la Vida al Màxim/Vivir la Vida al Máximo) and Counseling in people with Anxiety and Depression, run by University Rovira i Virgili at 3 sites in Spain.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 2 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: under way, not looking for participants, as of the sponsor's last update on 5 May 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 3 sites in Spain. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Anxiety (time frame: From enrollment to 6 months after being randomized). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 5 May 2026; AzTrials last refreshed its copy on 5 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in